AEON Biopharma, Inc. (New York Stock Exchange Arca:AEON)
| Market Cap | 13.98M-66.5% |
| Revenue (ttm) | 0 |
| Net Income | -54.62M-3238.8% |
| EPS | -3.77+35.1% |
| Shares Out | 44.16M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 623,896 |
| Open | 0.31 |
| Previous Close | 0.31 |
| Day's Range | 0.29 - 0.32 |
| 52-Week Range | 0.18 - 1.45 |
| Beta | 0.69 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About AEON
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$AEON stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in AEON holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AEON's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AEON Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New AEON patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AEON from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AEON
| ETF | Est. Holding Size |
|---|---|
| SPEMState Street SPDR Portfolio Emerging Markets ETF | $3.15M |
| EWXState Street SPDR S&P Emerging Markets Small Cap ETF | $204.24K |
| VXFVanguard Extended Market ETF | $26.79K |
Estimated from each fund’s disclosed top holdings × AUM
AEON Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from AEON’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score